Health Sector Corruption: Namibia Must Act Before Shortages Become the Norm

Reports that the Ministry of Health and Social Services has uncovered suspected fraud within Namibia’s pharmaceutical supply chain – including alleged manipulation of stock records and diversion of medicines at the Central Medical Stores – should concern every Namibian.

These developments help explain why hospitals are experiencing shortages of critical medicines such as anaesthetic agents, and why elective surgeries have reportedly been suspended at facilities like Onandjokwe State Hospital.

This situation is not merely a logistical failure. It is a systemic governance problem.

The suggestion that shortages may have been artificially created to trigger emergency procurement processes is particularly concerning.

If proven true, it would represent one of the most serious breaches of trust in Namibia’s public health system.

The health ministry’s decision to launch investigations and temporarily reassign staff implicated in the alleged irregularities is therefore an important immediate step.

However, while reassignment is necessary at the start of an investigation, experience across Namibia’s public institutions shows that reassignment alone does not resolve systemic weaknesses.

Without thorough investigation, accountability and structural reform, similar problems can reappear elsewhere in the system.

Addressing the root causes of medicine diversion and stock manipulation is therefore essential if public confidence in the national pharmaceutical supply chain is to be fully restored.

CHRONIC MALAISE

The current revelations did not arise in isolation but are symptoms of a deeper condition.

For years, Namibia’s pharmaceutical procurement system has shown warning signs: delayed deliveries, under-delivery of tendered medicines, unexplained stock-outs, and repeated concerns about weaknesses in procurement oversight.

Investigations by the Anti-Corruption Commission into fraud cases linked to the ministry of health further confirm that weaknesses in procurement and stock-management systems are not new challenges but persistent structural risks.

When essential medicines disappear from warehouses, stock levels are altered electronically, or emergency procurement becomes routine rather than exceptional, the consequences are immediate and dangerous.

Patients wait longer for treatment. Surgeries are postponed. Clinicians are forced to improvise.

Ultimately, lives are placed at risk.

THE ANATOMY OF A SHORTAGE

Why do shortages persist despite national investment?

Namibia does not suffer from a lack of commitment to healthcare funding. Instead, shortages persist because of weaknesses across multiple points in the pharmaceutical supply chain.

First, procurement decisions are sometimes influenced by suppliers with limited pharmaceutical expertise or delivery capacity.

Second, there appears to be insufficient pharmaceutical expertise embedded within procurement evaluation structures.

The distinction between pharmaceutical manufacturing, importing, wholesaling and repackaging is not an administrative detail – it determines whether suppliers can reliably deliver life-saving medicines.

Third, stock management systems remain vulnerable to manipulation of inventory controls and can be altered internally without independent audit safeguards.

Fourth, emergency procurement mechanisms – designed to protect patients during crises – risk becoming entry points for irregular supply decisions if oversight is weak.

Taken together, these weaknesses create an environment in which artificial shortages can occur even when medicines have already been purchased.

THE HUMAN COST

Medicine shortages are not abstract administrative failures.
They translate directly into cancelled surgical procedures, delayed cancer treatment, interrupted antibiotic therapy and compromised maternal care.
A functioning pharmaceutical supply chain is the backbone of any healthcare system. When that backbone weakens, the entire system becomes unstable.
Namibia already has the expertise to fix this: trained pharmacists, pharmaceutical technologists, pharmacist assistants and industrial pharmacy specialists with many years of experience.
Yet too few of these professionals are systematically integrated into procurement oversight, supply-chain monitoring, and tender evaluation processes.
Pharmaceutical supply systems cannot be managed effectively without pharmaceutical expertise.

WHAT NEEDS TO HAPPEN NEXT?

Investigations alone will not solve the underlying problem unless they are followed by structural reform.

Sustainable solutions require both accountability for wrongdoing and the strengthening of the systems that allowed these weaknesses to develop in the first place.

The following five urgent interventions are needed:

• stronger pharmaceutical representation in procurement evaluation committees,
• secure digital stock management audit trails,
• independent oversight of emergency procurement triggers,
• stricter supplier technical qualification requirements, and
• stronger whistleblower protection mechanisms.

These reforms are achievable within existing institutional structures if there is political will.

Namibia’s medicine supply system must serve patients first. This is a moment for decisive action.

• Seth !Nowaseb is an industrial pharmacist and academic involved in training pharmaceutical manufacturing and supply-chain professionals in Namibia. He writes in his personal capacity.

The post Health Sector Corruption: Namibia Must Act Before Shortages Become the Norm appeared first on The Namibian.